摘要 |
The invention relates to retroviral protease inhibitors of the general formula (I): W-(A)n-B-(A*)m-V where W, A, B, A*, V, n and m are as dofined herein, including related prodrugs of general formula (I) comprising a solubilising group which is labile in vivo.
|